Paul Steinberg, MD, Reads from His Book, “A Salamander’s Tale.”
Welcome to The Not Old Better Show, I’m Paul Vogelzang, and this is episode #215.
Yesterday, May 8, 2018, the U.S. Preventive Services Task Force (USPSTF) updated its prostate cancer screening recommendation statement to recommend that clinicians offer individualized PSA screening for men aged 55 to 69.
Why the change?
Well in men age 55 to 69 prostate specific antigen or PSA screening yields a small potential benefit. Studies show that of 1000 men offered PSA based screening 240 get a positive result. Of those, 140 positive PSA results are false positives while 100 of the 240 get a positive biopsy showing definite cancer. 20 to 50 of the 100 with definite cancer will have cancer that never grows spreads or harms them.
That is cancer over-diagnosis.
And, America’s longest living prostate cancer survivor reads from his memoir about his long journey, “A Salamander’s Tale.”